Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026)
Scynexis' (SCYX) quarterly Change in Acquisitions & Divestments came in at $2.8 million in Q1 2026, down 77.89% YoY from $12.4 million in Q1 2025, and down 61.15% on a QoQ basis from $7.1 million in Q4 2025.
Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Scynexis (SCYX) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $2.8 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 77.89% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 million (down 28.75% YoY) and the FY2025 annual result came in at $43.2 million, up 1.51% from the prior year.
- Change in Acquisitions & Divestments eased to $2.8 million in Q1 2026, from $7.1 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $20.6 million in Q2 2023 to a low of $2.8 million in Q1 2026.
- A 4-year average of $11.6 million and a median of $10.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 56.2% — and 2026, when it sank 77.89%.
- Tracing SCYX's Change in Acquisitions & Divestments over 4 years: stood at $10.1 million in 2023, then slumped by 42.16% to $5.8 million in 2024, then rose by 21.74% to $7.1 million in 2025, then plunged by 61.15% to $2.8 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $2.8 million (Q1 2026), $7.1 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.46 Mn |
| Jun 30, 2026 | 11.46 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Sep 30, 2025 | 12.42 Mn |
| Sep 30, 2025 | 12.42 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Sep 30, 2024 | 19.21 Mn |
| Sep 30, 2024 | 19.21 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Mar 31, 2024 | 7.96 Mn |